Mo Cheng

Department Of Head And Neck Oncology
Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Synchronous mucosa-associated lymphoid tissue lymphoma in a married couple: a case report.

Synchronous mucosa-associated lymphoid tissue lymphoma in a married couple: a case report.

Journal: Frontiers in oncology
Published: May 01, 2026

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial.

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial.

Journal: BMJ open
Published: January 09, 2026

Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.

Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.

Journal: International journal of cancer
Published: January 05, 2026

Antibody-drug conjugates in gastric cancer: clinical advances and resistance mechanisms.

Antibody-drug conjugates in gastric cancer: clinical advances and resistance mechanisms.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: September 11, 2025

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial.

XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial.

Journal: Frontiers in immunology
Published: July 24, 2025

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report.

Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report.

Journal: Frontiers in immunology
Published: May 08, 2025

Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors.

Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors.

Journal: Cancer medicine
Published: March 26, 2025

Unveiling promising targets in gastric cancer therapy: A comprehensive review.

Unveiling promising targets in gastric cancer therapy: A comprehensive review.

Journal: Molecular therapy. Oncology
Published: September 16, 2024

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis.

MET inhibitors as salvage therapy for MET-amplified gastric cancer with pulmonary lymphangitis.

Journal: Precision clinical medicine
Published: August 12, 2024

Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review).

Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review).

Journal: Experimental and therapeutic medicine
Published: March 22, 2023

Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.

Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.

Journal: Cancer medicine
Published: July 21, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026